Drug Candidate Name
Drug Candidate Description

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Company Name
Company Information
GET IN TOUCH

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Drug Candidates
Therapeutic AreaCardiovascular Diseases
IndicationLipid metabolism disorders
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationDyslipidaemias
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationHyperlipidaemia
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationHypertriglyceridaemia
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationHyperlipoproteinaemia
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationHypercholesterolaemia
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationCardiovascular disorders
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationNutritional and metabolic diseases
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationMetabolic disorders
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
IndicationAtherosclerosis
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Drug Class
Cardiovascular therapiesAntihyperlipidaemicsHMG-CoA Reductase Inhibitors (Statins)Atorvastain
Mechanism of Action
Cell physiology modulators, Enzyme modulators, Reductase inhibitors, HMG-CoA reductase inhibitors, Cytochrome P-450 enzyme system modulators, TNF related apoptosis inducing ligand modulators, Cell death modulators, Oxidoreductase inhibitors, Ferroptosis modulators, Reductase inhibitors, Reductase modulators, Oxidoreductase modulators, Enzyme inhibitors
New Molecular Entity
Shelved
Attachments and Links
Non-Confidential Information
Drug candidate and company presentations; links to publications, clinical trials, press releases, videos and medias